No Picture
News

Positive Top-Line Results of Pfizer’s Phase 3 Study Exploring Coadministration of PREVNAR 20™ With Pfizer-BioNTech COVID-19 Vaccine in Older Adults Released

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced positive top-line results from a Phase 3 study (B74710126) describing the safety and immunogenicity of PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) in 570 adults in the United States […]

No Picture
News

Global Pharma and Biotech Preclinical Stage Partnering Deal Report/Directory 2021: Headline, Upfront, Royalty Data, Company A-Z, Headline Value, Stage of Development, Deal Type, Specific Therapy

DUBLIN: DUBLIN, Jan. 12, 2022 /PRNewswire/ — The "Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021" report has been added to ResearchAndMarkets.com’s offering. The Global Preclinical Stage Partnering Terms and Agreements […]

No Picture
News

Covid-19 roundup: US buys more of the only antibody that works against Omicron; BioNTech taps AI to detect new variants faster

GlaxoSmithKline and Vir’s monoclonal antibody sotrovimab is still the only mAb treatment that works against the Omicron variant, and the US on Tuesday boosted its supply again. This latest deal, the financial details of which […]